Rydex Biotechnology Fund Investor (RYOIX)
78.65
+1.63
(+2.12%)
USD |
May 20 2026
RYOIX Asset Allocations & Exposures
Asset Allocation
As of March 31, 2026.
| Type | % Net |
|---|---|
| Cash | 0.56% |
| Stock | 98.66% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.78% |
Market Capitalization
As of March 31, 2026
| Large | 35.11% |
| Mid | 17.50% |
| Small | 47.39% |
Region Exposure
| Americas | 85.63% |
|---|---|
|
North America
|
85.63% |
| United States | 85.63% |
|
Latin America
|
0.00% |
As of March 31, 2026. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 13.03% |
|---|---|
| United Kingdom | 3.00% |
|
Europe Developed
|
10.02% |
| Denmark | 1.01% |
| Germany | 1.06% |
| Ireland | 2.93% |
| Netherlands | 1.60% |
| Switzerland | 3.41% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 1.34% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
100.0% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
100.0% |
| Utilities |
|
0.00% |
| Not Classified |
|
0.00% |
| Non Classified Equity |
|
0.00% |
| Not Classified - Non Equity |
|
0.00% |
As of March 31, 2026
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |